Lassonde Industries (LAS-A) Q4 2025 earnings summary

Executive summary

• Achieved record sales and strong profitability in 2025, with all divisions posting sales growth year-over-year despite a challenging macroeconomic environment and resilient business model.

• Fourth quarter sales rose 4.1% to $768.1M/CAD 768 million, and net profit nearly doubled to $54 million, reflecting effective strategy execution and commercial discipline.

• Growth was driven by effective pricing in Canada, higher U.S. sales volume, and a diversified product portfolio.

• Strategic focus on innovation, portfolio diversification, and operational agility supported resilience and market share gains.

• Continued execution of strategic initiatives, including on-budget construction of a new facility in New Jersey, scheduled for completion in early 2027.

Financial highlights

• Fiscal 2025 sales reached $2,934.0M/CAD 2.9 billion, up 12.8% year-over-year; Q4 sales were $768.1M/CAD 768 million, up 4.1%, entirely organic growth.

• Q4 gross profit was $225.0M (29.3% of sales), up 16.6% year-over-year, driven by pricing and favorable sales mix.

• Adjusted EBITDA for Q4 was $102 million/$101.8M (13.3% margin), up 28%/27.9% year-over-year; full-year adjusted EBITDA was $344.1M (11.7% margin), up 24.7%.

• Q4 adjusted EPS was $7.52, up 46.6% year-over-year; full-year adjusted EPS was $22.82, up 19.8%.

• Q4 operating profit rose to $71.1M, up 65.3% year-over-year; full-year operating profit was $226.1M, up $51.4M.

Outlook and guidance

• Targeting $3 billion/CAD 3 billion in sales for 2026, with balanced contributions from pricing and volume, and focus on profitable and sustainable growth.

• Plans to maintain leverage ratio below 2:1, well within comfort zone.

• Strategic priorities include capacity expansion, innovation, and disciplined pricing across divisions.

• Commodity cost environment expected to remain mixed, with some relief in orange concentrate but continued inflationary pressures on other inputs and higher transportation costs.

• Effective tax rate for 2026 estimated at 22.5%; capital expenditures projected up to 7% of sales, including $96M for the New Jersey plant.